{"database": "openregs", "table": "documents", "rows": [["FDA-1995-S-0039-0069", "FDA", "FDA-1995-S-0039", "Report 322 - Appendix I - \"Metabolic pathway of SDG conversion to Enterolactone (EL) and Enterodiol (ED) \" - [Archer Daniels Midland Company - BeneFlax Flax Lignans]", "Supporting & Related Material", "RPT-Report (Supporting and Related Material)", "2008-10-23T04:00:00Z", 2008, 10, null, null, "2016-09-30T14:22:32Z", null, 0, 0, "090000648055f2be"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1995-S-0039-0069"], "units": {}, "query_ms": 0.2849790034815669, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}